Apple-CPET Ted Rogers Understanding Exacerbations of Heart Failure

NCT05008692 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-11-16

No results posted yet for this study

Summary

Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrumental in determining the prognosis of patients with HF. This study will evaluate whether aggregate biometric data from the Apple Watch combined with demographic, cardiac, and biomarker testing can improve our ability to predict heart failure outcomes among a diverse ambulatory HF population

Conditions

  • Heart Failure
  • Heart Failure, Systolic
  • Heart Failure, Diastolic
  • Heart Transplantation
  • Heart Failure,Congestive

Sponsors & Collaborators

  • Apple Inc.

    collaborator INDUSTRY
  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Heather J Ross, MD · University Health Network, Toronto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-07-31
Completion
2023-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05008692 on ClinicalTrials.gov